Tags : Multiple Therapeutic Areas

AbbVie Signs an Exclusive Agreement with Scripps Research to Develop

Shots: Scripps Research to receive up front, development & commercialization milestones, option exercise fee and royalties on sales of new therapies and will conduct pre-clinical R&D activities and P-I studies (in some cases) while AbbVie get an exclusive option to further develop and commercialize therapies for cancer, immunology, neurology and fibrosis The collaboration marks the […]Read More